Jan 11, 2021
The Foundation for Sarcoidosis Research is dedicated to the health and safety of our patients. Since the COVID-19 vaccines have been released for distribution, we have received a lot of questions. We continue to monitor this situation and want to provide you who the...Topics: COVID-19/ News
Dec 17, 2020
Early Investigator Grant Opportunity The Foundation for Sarcoidosis Research (FSR) is seeking proposals from US-based early-stage investigators for a grant that provides support for a collaborative and translational research project that will positively impact...Topics: Research
Dec 17, 2020
Xentria Inc. has recently announced they received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for their intravenous TNF-inhibitor, XTMAB-16. The FDA grants orphan status to drugs being developed to treat those with rare diseases. This...Topics: Community Partners/ Research
Dec 17, 2020
Program supports specialized skill development of early-career physicians and researchers interested in studying sarcoidosis CHICAGO, Dec. 17, 2020 /PRNewswire/ — The Foundation for Sarcoidosis Research (FSR) is pleased to announce the opening of a new...Topics: Research
